Physician profile
Lanier Jackson
NPI 1982862389
$3,747.94
in general payments reported to CMS, 2019-2025
7 companies · $1,050 in 2025
The $1,050 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $16.35 · 2021: $24.31 · 2022: $1,020 · 2023: $896 · 2024: $600 · 2025: $1,050.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,341 · Food and Beverage: $1,205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,340.55 |
| Food and Beverage | $1,205.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,807.54 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Concertotm |
| Abbott Laboratories | $1,513.71 | 2022-2025 | Ensite Precision, Amplatzer Talisman, Na |
| Cardiva Medical, INC. | $184.92 | 2024 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 5f Vcs |
| Medtronic Vascular, INC. | $158.05 | 2019-2020 | |
| Boston Scientific Corporation | $34.03 | 2023 | |
| B. Braun Interventional Systems INC. | $25.06 | 2025 | Cp Stent |
| Biotronik INC. | $24.63 | 2023 | Acticor 7 Vr-T Dx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lanier Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.